Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration

Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration

Patients with non-valvular atrial fibrillation (NVAF) exhibit a high risk of stroke, which is associated with high mortality. Thus, stroke prevention is crucial for the overall management of NVAF. Two categories of drugs, vitamin K antagonist warfarin and non-vitamin K antagonist oral anticoagulants...

Full description

Bibliographic Details
Main Authors: Shujuan Zhao, Xuejiao Hong, Jingjing Cao, Haixia Cai, Song Du, Peizhi Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Pharmacology
Subjects:
stroke prevention
non-valvular atrial fibrillation
non-vitamin K antagonist oral anticoagulants
clinical settings
dosing regimens
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.01293/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.01293/full

Similar Items